Abstract
Critical care for advanced lung cancer patients is still controversial, and the appropriate method for the selection of patients who may benefit from intensive care unit (ICU) care is not clearly defined. We retrospectively reviewed the medical records of stage IIIB–IV lung cancer patients admitted to the medical ICU of a university hospital in Korea between 2003 and 2011. Of 95 patients, 64 (67 %) had Eastern Cooperative Oncology Group (ECOG) performance status (PS) ≥2, and 79 (84 %) had non-small-cell lung cancer. In total, 28 patients (30 %) were newly diagnosed or were receiving first-line treatment, and 22 (23 %) were refractory or bedridden. Mechanical ventilation was required in 85 patients (90 %), and ICU mortality and hospital mortality were 57 and 78 %, respectively. According to a multivariate analysis, a PaO2/FiO2 ratio <150 [odds ratio (OR) = 5.51, 95 % confidence interval (CI) 2.10–14.48, p = 0.001] was independently associated with ICU mortality, and an ECOG PS ≥2 (OR = 9.53, 95 % CI 2.03–44.85, p = 0.004) and a need for vasoactive agents (OR = 6.94, 95 % CI 1.61–29.84, p = 0.009) were independently associated with hospital mortality. Refractory or bedridden patients (n = 22) showed significantly poorer overall survival (11.0 vs. 29.0 days, p = 0.005). Among 21 patients who were discharged from the hospital, 11 (52 %) received further chemotherapy. Certain advanced lung cancer patients may benefit from ICU management. However, refractory patients and patients with a poor PS do not seem to benefit from ICU care. Oncologists should try to discuss palliative care and end-of-life issues in advance to avoid futile care.
Similar content being viewed by others
References
Jung KW, Won YJ, Kong HJ, Oh CM, Seo HG, Lee JS. Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010. Cancer Res Treat. 2013;45(1):1–14.
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.
Kress JP, Christenson J, Pohlman AS, Linkin DR, Hall JB. Outcome of critically ill patients in a university hospital setting. Am J Respir Crit Care Med. 1999;160(6):1957–61.
Carlon GC. Admitting cancer patients to the intensive care unit. Crit Care Clin. 1988;4:183–91.
Schuster DP. Everything that should be done: not everything that can be done. Am Rev Respir Dis. 1992;145:508–9.
Pène F, Percheron S, Lemiale V, Viallon V, Claessens YE, Marqué S, Charpentier J, Angus DC, Cariou A, Chiche JD, Mira JP. Temporal changes in management and outcome of septic shock in patients with malignancies in the intensive care unit. Crit Care Med. 2008;36:690–6.
Ewer MS, Ali MK, Atta MS, Morice RC, Balakrishnan PV. Outcome of lung cancer patients requiring mechanical ventilation for pulmonary failure. JAMA. 1986;256(24):3364–6.
Boussat S, El’rini T, Dubiez A, Depierre A, Barale F, Capellier G. Predictive factors of death in primary lung cancer patients on admission to the intensive care unit. Intensive Care Med. 2000;26:1811–6.
Lin YC, Tsai YH, Huang CC, Hsu KH, Wang SW, Tsao TC, Lin MC. Outcome of lung cancer patients with acute respiratory failure requiring mechanical ventilation. Respir Med. 2004;98(1):43–51.
Reichner CA, Thompson JA, O’Brien S, Kuru T, Anderson ED. Outcome and code status of lung cancer patients admitted to the medical ICU. Chest. 2006;130:719–23.
Soares M, Darmon M, Salluh JI, Ferreira CG, Thiéry G, Schlemmer B, Spector N, Azoulay E. Prognosis of lung cancer patients with life-threatening complications. Chest. 2007;131:840–6.
Adam AK, Soubani AO. Outcome and prognostic factors of lung cancer patients admitted to the medical intensive care unit. Eur Respir J. 2008;31:47–53.
Roques S, Parrot A, Lavole A, Ancel PY, Gounant V, Djibre M, Fartoukh M. Six-month prognosis of patients with lung cancer admitted to the intensive care unit. Intensive Care Med. 2009;35:2044–50.
Toffart AC, Minet C, Raynard B, Schwebel C, Hamidfar-Roy R, Diab S, Quetant S, Moro-Sibilot D, Azoulay E, Timsit JF. Use of intensive care in patients with nonresectable lung cancer. Chest. 2011;139(1):101–8.
Bonomi MR, Smith CB, Mhango G, Wisnivesky JP. Outcomes of elderly patients with stage IIIB–IV non-small cell lung cancer admitted to the intensive care unit. Lung Cancer. 2012;77:600–4.
Andréjak C, Terzi N, Thielen S, Bergot E, Zalcman G, Charbonneau P, Jounieaux V. Admission of advanced lung cancer patients to intensive care unit: a retrospective study of 76 patients. BMC Cancer. 2011;11:159.
Chou KT, Chen CS, Su KC, Hung MH, Hsiao YH, Tseng CM, Chen YM, Lee YC, Perng DW. Hospital outcomes for patients with stage III and IV lung cancer admitted to the intensive care unit for sepsis-related acute respiratory failure. J Palliat Med. 2012;15(11):1234–9.
Soubani AO, Ruckdeschel JC. The outcome of medical intensive care for lung cancer patients: the case for optimism. J Thorac Oncol. 2011;6:633–8.
Slatore CG, Cecere LM, Letourneau JL, O’Neil ME, Duckart JP, Wiener RS, Farjah F, Cooke CR. Intensive care unit outcomes among patients with lung cancer in the surveillance, epidemiology, and end results-medicare registry. J Clin Oncol. 2012;30(14):1686–91.
Sharma G, Freeman J, Zhang D, Goodwin JS. Trends in end-of-life ICU use among older adults with advanced lung cancer. Chest. 2008;133:72–8.
Ho TH, Barbera L, Saskin R, Lu H, Neville BA, Earle CC. Trends in aggressiveness of end-of-life cancer care in the universal health care system of Ontario Canada. J Clin Oncol. 2011;29(12):1587–91.
Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363(8):733–42.
Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992;101(6):1644–55.
Azoulay E, Afessa B. The intensive care support of patients with malignancy: do everything that can be done. Intensive Care Med. 2006;32:3–5.
Darmon M, Azoulay E. Critical care management of cancer patients: cause for optimism and need for objectivity. Curr Opin Oncol. 2009;21:318–26.
Little AG, Gay EG, Gaspar LE, Stewart AK. National survey of non-small cell lung cancer in the United States: epidemiology, pathology and patterns of care. Lung Cancer. 2007;57:253–60.
Lim T, Nam SH, Kim MS, Yoon KS, Kim BS. Comparison of medical expenditure according to types of hospice care in patients with terminal cancer. Am J Hosp Palliat Care. 2013;30(1):50–2.
Soares M, Caruso P, Silva E, Teles JM, Lobo SM, Friedman G, Dal-Pizzol F, Mello PV, Bozza FA, Silva UV, Torelly AP, Knibel MF, Rezende E, Netto JJ, Piras C, Castro A, Ferreira BS, Réa-Neto A, Olmedo PB, Salluh JI, Brazilian Research in Intensive Care Network (BRICNet). Characteristics and outcomes of patients with cancer requiring admission to intensive care units: a prospective multicenter study. Crit Care Med. 2010;38(1):9–15.
Mendoza V, Lee A, Marik PE. The hospital-survival and prognostic factors of patients with solid tumors admitted to an ICU. Am J Hosp Palliat Care. 2008;25:240–3.
Soares M, Salluh JI, Spector N, Rocco JR. Characteristics and outcomes of cancer patients requiring mechanical ventilatory support for >24 h. Crit Care Med. 2005;33(3):520–6.
Conflict of interest
The authors have declared no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Yu Jung Kim and Mi-Jung Kim have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Kim, Y.J., Kim, MJ., Cho, YJ. et al. Who should be admitted to the intensive care unit? The outcome of intensive care unit admission in stage IIIB–IV lung cancer patients. Med Oncol 31, 847 (2014). https://doi.org/10.1007/s12032-014-0847-1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12032-014-0847-1